OncoMed Pharmaceuticals

BiotechnologySeries BRedwood City, USoncomed.com

Latest round

Series B

Last raised

Dec 2008

Total raised

$104M

Investors

12

About OncoMed Pharmaceuticals

OncoMed Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapeutics for cancer treatment.OncoMed Pharmaceuticals, Inc. was founded in 2004 in Redwood City, US, focusing on drug development for oncology.8 million shares at USD 17 per share.OncoMed Pharmaceuticals specializes in creating monoclonal antibodies aimed at targeting cancer stem cells. The company aims to expand its market presence in North America and Europe, targeting specific cancer indications by 2025. Ongoing collaborations are expected to facilitate the commercialization of promising therapies as they progress through clinical trials.

Who invested in OncoMed Pharmaceuticals

12 investors across 3 rounds

See all investors in OncoMed Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 12, 2008

    Amount

    $47M

    Investors

    Locked

  2. Series C

    Jul 16, 2008

    Amount

    $43M

    Investors

    Locked

  3. Series A

    Sep 7, 2005

    Amount

    $14M

    Investors

    Locked

Questions about OncoMed Pharmaceuticals

Who invested in OncoMed Pharmaceuticals?

OncoMed Pharmaceuticals has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has OncoMed Pharmaceuticals raised?

OncoMed Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did OncoMed Pharmaceuticals last raise money?

OncoMed Pharmaceuticals's most recent round on record is a Series B, in Dec 2008.

What does OncoMed Pharmaceuticals do?

OncoMed Pharmaceuticals is a biotechnology company.

Where is OncoMed Pharmaceuticals headquartered?

OncoMed Pharmaceuticals is headquartered in Redwood City, US.

Which VCs invest in companies like OncoMed Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OncoMed Pharmaceuticals's stage. Their profiles are linked below.

Raising like OncoMed Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.